Merrimack Pharmaceuticals, Inc. MACK
Set alert
15.15 +15.15 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 223.75M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 100.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -8.50
- Beta
- 1.42
- Short ratio
- 8.65
- Inst. own
- 62.98%
- Dividend
- 15.10
- Ex-div date
- May 8, 2024
- Earnings
- May 15, 2024
- 50-d avg
- 14.84
- 200-d avg
- 13.48
- 1y target
- 0.00
Peers
Companies in the same industry
| Symbol | Name | Last | Change | Change % | YTD | Market cap |
|---|---|---|---|---|---|---|
| SNY | Sanofi | 44.34 | +1.21 | +2.81% | -8.50% | 106.24B |
| AVEO | AVEO Pharmaceuticals, Inc. | 15.00 | +15.00 | — | — | 521.45M |
| GERN | Geron Corporation | 0.8944 | -0.05 | -5.47% | -32.24% | 574.63M |
| CLVS | Clovis Oncology, Inc. | 0.0812 | +0.08 | — | — | 11.77M |
| BTX | BlackRock Innovation and Growth Term Trust | 8.44 | -0.35 | -3.98% | +28.07% | 985.03M |